According to the latest report of the IMARC group, entitled “Antirheumatics Market: Global Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, The global antirheumatic drugs market showed moderate growth over the period 2015-2020. Going forward, the market is projected to grow at a CAGR of around 4% during the period 2021-2026.
Antirheumatics refer to drugs used to treat rheumatoid arthritis, a chronic inflammatory disease. Anti-rheumatic drugs are commonly prescribed by medical professionals to halt the progression of the disease. Apart from this, it is also used to treat inflammatory myositis, bowel disease, and cancer.
Get PDF sample for more detailed market information: https://www.imarcgroup.com/anti-rheumatics-market/requestsample
The global market is mainly driven by the increasing incidence of rheumatoid arthritis across the world. Along with this, the widespread adoption of biosimilars and new biologic therapies among the masses is also contributing to the growth of the market. Additionally, the increasing prevalence of acute and chronic diseases, such as systemic sclerosis, systemic lupus erythematosus and Sjogren’s syndrome, is driving the demand for anti-rheumatic drugs across the world. Other factors including growing investments by public and private companies to upgrade the existing healthcare infrastructure and extensive research and development (R&D) activities by key players are further driving the market growth.
Note: We regularly track the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.
The competitive landscape of the industry has also been reviewed along with the profiles of key players.
- AbbVie Inc. (ABBV)
- Amgen Inc.
- Astra Zeneca plc
- Biogene Inc.
- Bristol-Myers Squibb Company
- Celltrion inc.
- Eli Lilly and company
- Hoffmann-La Roche SA
- Johnson Johnson
- Pfizer Inc.
- Sanofi SA.
Ask before you buy – https://www.imarcgroup.com/request?type=report&id=4148&flag=F
The report has segmented the market on the basis of type, drug class, route of drug administration, distribution channel, and region.
Breakdown by type:
- Prescription drugs
- Over-the-counter medications
Breakdown by drug class:
- Disease Modifying Antirheumatic Drugs (DMARDs)
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Uric acid drugs
Distribution by route of drug administration:
Breakdown by distribution channel:
- Hospital pharmacies
- Retail pharmacies
Breakdown by region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Browse Other reports from the IMARC group:
Metal Foil Tapes Market Report 2021-2026: Industry Outlook, Size, Share, Analysis and Forecast
Epoxy Curing Agents Market Research Report 2022-27: Trends, Share, Size, Competitive Landscape and Opportunities
Managed Print Services Market Research Report 2021-2026 | Analysis, Key Players, Size and Forecast
Vaccine Adjuvants Market Report Forecast 2021 to 2026: Growth, Size, Share, Trends and Analysis
Advanced Distribution Management System Market 2022-2027 | Industry Trends, Size, Share and Forecasts
Electric Axles Market Research Report 2022-2027 | Industry Size, Share, Trends, Growth and Forecast
Insurance Analytics Market Report 2022-2027 | Industry Size, Share, Trends, Analysis & Forecast
The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 United States
Such. :(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800